Allakos Inc (NASDAQ:ALLK) — Market Cap & Net Worth
Market Cap & Net Worth: Allakos Inc (ALLK)
Allakos Inc (NASDAQ:ALLK) has a market capitalization of $29.74 Million ($29.74 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23861 globally and #5095 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Allakos Inc's stock price $0.33 by its total outstanding shares 90377000 (90.38 Million). Review ALLK current and long-term liabilities to assess the company's total debt and financial obligations.
Allakos Inc Market Cap History: 2018 to 2025
Allakos Inc's market capitalization history from 2018 to 2025. Data shows change from $4.72 Billion to $29.74 Million (-48.69% CAGR).
Index Memberships
Allakos Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.00% | #686 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2260 of 3165 |
Weight: Allakos Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Allakos Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Allakos Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ALLK by Market Capitalization
Companies near Allakos Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Allakos Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #444 globally with a market cap of $62.63 Billion USD.
- UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $458.99 |
| #444 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.63 Billion | $607.93 |
| #549 | UCB SA | BR:UCB | $49.68 Billion | €252.40 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €780.20 |
Allakos Inc Historical Marketcap From 2018 to 2025
Between 2018 and today, Allakos Inc's market cap moved from $4.72 Billion to $ 29.74 Million, with a yearly change of -48.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $29.74 Million | -72.80% |
| 2024 | $109.36 Million | -55.68% |
| 2023 | $246.73 Million | -67.58% |
| 2022 | $760.97 Million | -13.99% |
| 2021 | $884.79 Million | -93.01% |
| 2020 | $12.65 Billion | +46.81% |
| 2019 | $8.62 Billion | +82.44% |
| 2018 | $4.72 Billion | -- |
End of Day Market Cap According to Different Sources
On May 13th, 2026 the market cap of Allakos Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.74 Million USD |
| MoneyControl | $29.74 Million USD |
| MarketWatch | $29.74 Million USD |
| marketcap.company | $29.74 Million USD |
| Reuters | $29.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Allakos Inc
As of May 15, 2025, operates as a subsidiary of Concentra Biosciences, LLC.